Sylvia G. Kachalsky

Sylvia G. Kachalsky

Corporate Officer/Principal at Molecular Detection, Inc.

Health Technology
Consumer Services
Transportation

Profile

Sylvia G.
Kachalsky
was the founder of Agazyme Ltd.
founded in 2007, where she held the title of Chief Executive Officer.
Currently, she is the Director-Process Development & Commercialization at Molecular Detection, Inc. Dr. Kachalsky's former positions include Consultant at NTG Nordic Transport Group A, Azign Bioscience AS, Interpharm Laboratories Ltd., and Serono Corp.
She was also the Head-Neurobiology & Animal Models at Quark Pharmaceuticals, Inc. Dr. Kachalsky holds a doctorate degree from the Weizmann Institute of Science and a graduate degree from The Hebrew University Hadassah Medical School.

Sylvia G. Kachalsky active positions

CompaniesPositionStart
Corporate Officer/Principal -
All active positions of Sylvia G. Kachalsky

Former positions of Sylvia G. Kachalsky

CompaniesPositionEnd
NTG NORDIC TRANSPORT GROUP A/S Corporate Officer/Principal -
Corporate Officer/Principal -
Serono Corp. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Sylvia G. Kachalsky's experience

Training of Sylvia G. Kachalsky

Weizmann Institute of Science Doctorate Degree
The Hebrew University Hadassah Medical School Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sylvia G. Kachalsky's experience

Connections

7

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NTG NORDIC TRANSPORT GROUP A/S

Transportation

Private companies6

Health Technology

Health Technology

Health Technology

Serono Corp.

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Sylvia G. Kachalsky